232 related articles for article (PubMed ID: 33761981)
1. Attenuated TGFB signalling in macrophages decreases susceptibility to DMBA-induced mammary cancer in mice.
Sun X; Bernhardt SM; Glynn DJ; Hodson LJ; Woolford L; Evdokiou A; Yan C; Du H; Robertson SA; Ingman WV
Breast Cancer Res; 2021 Mar; 23(1):39. PubMed ID: 33761981
[TBL] [Abstract][Full Text] [Related]
2. CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model.
Sun X; Glynn DJ; Hodson LJ; Huo C; Britt K; Thompson EW; Woolford L; Evdokiou A; Pollard JW; Robertson SA; Ingman WV
Breast Cancer Res; 2017 Jan; 19(1):4. PubMed ID: 28077158
[TBL] [Abstract][Full Text] [Related]
3. Regulation of epithelial cell turnover and macrophage phenotype by epithelial cell-derived transforming growth factor beta1 in the mammary gland.
Sun X; Robertson SA; Ingman WV
Cytokine; 2013 Feb; 61(2):377-88. PubMed ID: 23290315
[TBL] [Abstract][Full Text] [Related]
4. Cytokine networks that mediate epithelial cell-macrophage crosstalk in the mammary gland: implications for development and cancer.
Sun X; Ingman WV
J Mammary Gland Biol Neoplasia; 2014 Jul; 19(2):191-201. PubMed ID: 24924120
[TBL] [Abstract][Full Text] [Related]
5. Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression.
Apostoli AJ; Roche JM; Schneider MM; SenGupta SK; Di Lena MA; Rubino RE; Peterson NT; Nicol CJ
Mol Cancer; 2015 Apr; 14():85. PubMed ID: 25889730
[TBL] [Abstract][Full Text] [Related]
6. Mammary gland development in transforming growth factor beta1 null mutant mice: systemic and epithelial effects.
Ingman WV; Robertson SA
Biol Reprod; 2008 Oct; 79(4):711-7. PubMed ID: 18614704
[TBL] [Abstract][Full Text] [Related]
7. Obesity reduces mammary epithelial cell TGFβ1 activity through macrophage-mediated extracellular matrix remodeling.
Chamberlin T; Thompson V; Hillers-Ziemer LE; Walton BN; Arendt LM
FASEB J; 2020 Jun; 34(6):8611-8624. PubMed ID: 32359100
[TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
Taylor MA; Amin JD; Kirschmann DA; Schiemann WP
Neoplasia; 2011 May; 13(5):406-18. PubMed ID: 21532881
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
[TBL] [Abstract][Full Text] [Related]
11. Consequences of epithelial or stromal TGFβ1 depletion in the mammary gland.
Nguyen DH; Martinez-Ruiz H; Barcellos-Hoff MH
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):147-55. PubMed ID: 21590374
[TBL] [Abstract][Full Text] [Related]
12. Cx26 knockout predisposes the mammary gland to primary mammary tumors in a DMBA-induced mouse model of breast cancer.
Stewart MK; Bechberger JF; Welch I; Naus CC; Laird DW
Oncotarget; 2015 Nov; 6(35):37185-99. PubMed ID: 26439696
[TBL] [Abstract][Full Text] [Related]
13. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
Böttinger EP; Jakubczak JL; Haines DC; Bagnall K; Wakefield LM
Cancer Res; 1997 Dec; 57(24):5564-70. PubMed ID: 9407968
[TBL] [Abstract][Full Text] [Related]
14. Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.
Roarty K; Baxley SE; Crowley MR; Frost AR; Serra R
Breast Cancer Res; 2009; 11(2):R19. PubMed ID: 19344510
[TBL] [Abstract][Full Text] [Related]
15. The role of activin in mammary gland development and oncogenesis.
Dunphy KA; Schneyer AL; Hagen MJ; Jerry DJ
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):117-26. PubMed ID: 21475961
[TBL] [Abstract][Full Text] [Related]
16. Role of 5-lipoxygenase in resveratrol mediated suppression of 7,12-dimethylbenz(α)anthracene-induced mammary carcinogenesis in rats.
Chatterjee M; Das S; Janarthan M; Ramachandran HK; Chatterjee M
Eur J Pharmacol; 2011 Oct; 668(1-2):99-106. PubMed ID: 21749863
[TBL] [Abstract][Full Text] [Related]
17. Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner.
Bohrer LR; Schwertfeger KL
Mol Cancer Res; 2012 Oct; 10(10):1294-305. PubMed ID: 22893608
[TBL] [Abstract][Full Text] [Related]
18. Activation of Akt1 accelerates carcinogen-induced tumorigenesis in mammary gland of virgin and post-lactating transgenic mice.
Wu Y; Kim J; Elshimali Y; Sarkissyan M; Vadgama JV
BMC Cancer; 2014 Apr; 14():266. PubMed ID: 24742286
[TBL] [Abstract][Full Text] [Related]
19. Noncanonical TGF-β signaling during mammary tumorigenesis.
Parvani JG; Taylor MA; Schiemann WP
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):127-46. PubMed ID: 21448580
[TBL] [Abstract][Full Text] [Related]
20. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Gonzalez-Suarez E; Jacob AP; Jones J; Miller R; Roudier-Meyer MP; Erwert R; Pinkas J; Branstetter D; Dougall WC
Nature; 2010 Nov; 468(7320):103-7. PubMed ID: 20881963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
